Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))

L. P. Stabile; G. He; V. W. Lui; S. Thomas; C. Henry; C. T. Gubish; S. Joyce; K. M. Quesnelle; J. M. Siegfried; Grandis

doi:10.1158/1078-0432.CCR-13-1344

Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))

L. P. Stabile, G. He, V. W. Lui, S. Thomas, C. Henry, C. T. Gubish, S. Joyce, K. M. Quesnelle, J. M. Siegfried, Grandis

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	3715
Number of pages	1
Journal	Clinical Cancer Research
Volume	19
Issue number	13
DOIs	https://doi.org/10.1158/1078-0432.CCR-13-1344
State	Published - Jul 1 2013
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-13-1344

Cite this

Stabile, L. P., He, G., Lui, V. W., Thomas, S., Henry, C., Gubish, C. T., Joyce, S., Quesnelle, K. M., Siegfried, J. M., & Grandis (2013). Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392)). Clinical Cancer Research, 19(13), 3715. https://doi.org/10.1158/1078-0432.CCR-13-1344

Stabile, LP, He, G, Lui, VW, Thomas, S, Henry, C, Gubish, CT, Joyce, S, Quesnelle, KM, Siegfried, JM & Grandis 2013, 'Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))', Clinical Cancer Research, vol. 19, no. 13, pp. 3715. https://doi.org/10.1158/1078-0432.CCR-13-1344

@article{de651278cf614313877437ed18b8b756,

title = "Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))",

author = "Stabile, {L. P.} and G. He and Lui, {V. W.} and S. Thomas and C. Henry and Gubish, {C. T.} and S. Joyce and Quesnelle, {K. M.} and Siegfried, {J. M.} and Grandis",

year = "2013",

month = jul,

day = "1",

doi = "10.1158/1078-0432.CCR-13-1344",

language = "English (US)",

volume = "19",

pages = "3715",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "13",

}

TY - JOUR

T1 - Correction

T2 - c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))

AU - Stabile, L. P.

AU - He, G.

AU - Lui, V. W.

AU - Thomas, S.

AU - Henry, C.

AU - Gubish, C. T.

AU - Joyce, S.

AU - Quesnelle, K. M.

AU - Siegfried, J. M.

AU - Grandis,

PY - 2013/7/1

Y1 - 2013/7/1

UR - http://www.scopus.com/inward/record.url?scp=84879870672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879870672&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-13-1344

DO - 10.1158/1078-0432.CCR-13-1344

M3 - Comment/debate

AN - SCOPUS:84879870672

SN - 1078-0432

VL - 19

SP - 3715

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 13

ER -

Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this